secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001380106-25-000195
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q3 revenue $7.8M (+3% YoY); raises FY guidance after record multi-system order
--------------------------------------------------------------------------------

- Q3 2025 revenue $7.8M (+3% YoY); recurring revenue up 32% to $4.8M on record consumables.
- Net loss $11.5M ($0.26 loss per share), flat YoY; gross margin improved to 9% from 8%.
- Receives largest multi-system order in company history from existing Top 20 global biopharma customer.
- Raises FY2025 revenue guidance to at least $33.0M, assumes at least 27 Growth Direct placements.
- Cash and equivalents $42M as of Sept 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000195/0001380106-25-000195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010625000195/rpid-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001380106-25-000195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer